PAOLINI PAOLETTI, FEDERICO
 Distribuzione geografica
Continente #
NA - Nord America 626
EU - Europa 277
AS - Asia 244
AF - Africa 1
SA - Sud America 1
Totale 1.149
Nazione #
US - Stati Uniti d'America 625
SG - Singapore 105
IE - Irlanda 104
IT - Italia 77
HK - Hong Kong 73
CN - Cina 49
FI - Finlandia 20
RO - Romania 20
DE - Germania 17
KR - Corea 8
RU - Federazione Russa 6
VN - Vietnam 6
FR - Francia 5
GB - Regno Unito 5
AT - Austria 4
NL - Olanda 4
UA - Ucraina 4
CH - Svizzera 2
SE - Svezia 2
AE - Emirati Arabi Uniti 1
BE - Belgio 1
BR - Brasile 1
CA - Canada 1
DK - Danimarca 1
EG - Egitto 1
ES - Italia 1
HR - Croazia 1
IS - Islanda 1
JP - Giappone 1
MD - Moldavia 1
SK - Slovacchia (Repubblica Slovacca) 1
UZ - Uzbekistan 1
Totale 1.149
Città #
Chandler 167
Dublin 104
Singapore 85
Hong Kong 72
Boardman 59
Santa Clara 38
San Mateo 35
Perugia 30
Timisoara 19
Helsinki 18
Lawrence 18
Medford 18
Princeton 18
Wilmington 17
Altamura 14
Falls Church 13
Andover 12
Des Moines 12
Ashburn 11
Redwood City 10
Seoul 8
Beijing 7
Los Angeles 6
Dong Ket 5
Fairfield 5
Redmond 5
Rome 5
Saint Petersburg 4
Cosenza 3
El Paso 3
Milan 3
San Paolo di Civitate 3
Brixen 2
Chicago 2
Dallas 2
Genoa 2
Lappeenranta 2
Munich 2
New York 2
Shanghai 2
Alviano 1
Amsterdam 1
Ann Arbor 1
Anshan 1
Brookfield 1
Brussels 1
Böblingen 1
Cairo 1
Changchun 1
Chisinau 1
Dubai 1
Frankfurt am Main 1
Fremont 1
Groningen 1
Guangzhou 1
Harbin 1
Hengshui 1
Ho Chi Minh City 1
Houston 1
Ma'anshan 1
Madrid 1
Montespertoli 1
Norwalk 1
Nuremberg 1
Radeberg 1
Reykjavik 1
Seattle 1
Secaucus 1
Shenzhen 1
São Paulo 1
Tappahannock 1
Tashkent 1
Tokyo 1
Trento 1
Vancouver 1
Wuhan 1
Zagreb 1
Zhengzhou 1
Zhoukou 1
Zwenkau 1
Totale 883
Nome #
CSF and Blood Biomarkers in Neuroinflammatory and Neurodegenerative Diseases: Implications for Treatment 74
A/T/(N) Profile in Cerebrospinal Fluid of Parkinson's Disease with/without Cognitive Impairment and Dementia with Lewy Bodies 61
Substantia nigra hyperechogenicity in essential tremor and Parkinson's disease: a longitudinal study 57
Unraveling Pathophysiological Mechanisms of Parkinson’s Disease: Contribution of CSF Biomarkers 54
Impulse Control Disorders and Levodopa-Induced Dyskinesias in Parkinson's Disease: Pulsatile versus Continuous Dopaminergic Stimulation 52
Changes of olfactory tract in Parkinson’s disease: a DTI tractography study 51
Measurement of CSF core Alzheimer disease biomarkers for routine clinical diagnosis: Do fresh vs frozen samples differ? 49
PEG-J replacement for duodenal levodopa infusion in Parkinson's disease patients: a retrospective study 48
Molecular profiling in Parkinsonian syndromes: CSF biomarkers 47
T2*-weighted MRI values correlate with motor and cognitive dysfunction in Parkinson's disease 45
Levodopa-responsive breathing discomfort in Parkinson’s disease patients 45
Risk factors of levodopa-induced dyskinesia in Parkinson's disease: results from the PPMI cohort 43
The Challenge of Disease-Modifying Therapies in Parkinson's Disease: Role of CSF Biomarkers. 42
Levodopa treatment in Parkinson's disease: earlier or later? 40
Cerebrospinal fluid levels of proenkephalin and prodynorphin are differentially altered in Huntington's and Parkinson's disease 39
Specific Cerebrospinal Fluid SerpinA1 Isoform Pattern in Alzheimer's Disease 38
High performance liquid chromatography determination of L-glutamate, L-glutamine and glycine content in brain, cerebrospinal fluid and blood serum of patients affected by Alzheimer's disease 38
Drug-induced Creutzfeldt-Jakob disease-like syndrome: Early CSF analysis as useful tool for differential diagnosis 37
Cerebrospinal fluid β-synuclein as a synaptic biomarker for preclinical Alzheimer's disease 32
α-Synuclein Seed Amplification Assays for Diagnosing Synucleinopathies: The Way Forward 31
Blood biomarkers may distinguish among dementia disorders 29
CSF neurochemical profile and cognitive changes in Parkinson's disease with mild cognitive impairment 28
Phosphatidylethanolamine Binding Protein 1 (PEBP1) in Alzheimer's Disease: ELISA Development and Clinical Validation 27
Alpha and Beta Synucleins: From Pathophysiology to Clinical Application as Biomarkers 25
Machine Learning Driven Profiling of Cerebrospinal Fluid Core Biomarkers in Alzheimer's Disease and Other Neurological Disorders 21
LRRK2 Quantification in Cerebrospinal Fluid of Patients with Parkinson's Disease and Atypical Parkinsonian Syndromes 21
Association between Neuropsychological Performance and CSF Profile in Subjective Cognitive Decline: Towards the Diagnosis of Preclinical AD 18
CSF Synaptic Biomarkers in AT(N)-Based Subgroups of Lewy Body Disease 17
Investigating alpha-synuclein co-pathology in Alzheimer's disease by means of cerebrospinal fluid alpha-synuclein seed amplification assay 16
Fully automated measurement of plasma Aβ42/40 and p-tau181: Analytical robustness and concordance with cerebrospinal fluid profile along the Alzheimer's disease continuum in two independent cohorts 16
Predictive value for cerebrospinal fluid Alzheimer's disease profile of different measures of verbal episodic memory in patients with MCI 12
Required improvements for cerebrospinal fluid-based biomarker tests of Alzheimer's disease 12
Hyposmia correlates with axial signs and gait disorder in Parkinson's disease: an Italian Olfactory Identification Test study 11
Safety and efficacy of concomitant treatment with non-vitamin K antagonist oral anticoagulants and antiseizure medications: A propensity score matching cohort study 9
Incidence and Risk Factors Epilepsy in Patients with Dementia: A Population-Based Study Using Regional Healthcare Databases in Umbria 8
CSF neurosecretory proteins VGF and neuroserpin in patients with Alzheimer's and Lewy body diseases 8
Research advancement in fluid biomarkers for Parkinson's disease 3
Totale 1.204
Categoria #
all - tutte 7.189
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.189


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202017 0 0 0 0 0 0 0 0 4 5 8 0
2020/202189 0 0 1 4 51 8 4 3 2 8 2 6
2021/2022134 0 23 0 0 5 8 4 34 10 11 20 19
2022/2023467 19 104 7 35 41 51 1 27 154 5 14 9
2023/2024253 16 25 8 4 4 2 42 6 46 12 45 43
2024/2025238 11 51 38 36 60 42 0 0 0 0 0 0
Totale 1.204